10 African Americans Who Have Shaped  Public Health

By Casey Bishopp, Communications officer, IntraHealth International ; Sabra Farquharson, Business development officer, IntraHealth InternationalFebruary 18, 2020We’re celebrating the legacies of ten African Americans in public health this month—shining a light on the invaluable contributions made by these scholars and health workers. According to themost recent report form the Health Resources and Services Administration, African Americans make up 11.6% of the US health workforce, and throughout American history have made invaluable contributions to greater public health in fields such as hematology, nursing, and microbiology.Tragically, these accomplishments happened in a system which historically subjugated and exploited black Americans—and many individuals were denied access to the very systems and institutions that they helped improve.African American History Month started with historian Dr. Carter G. Woodson, who worked to promote the study of African American history throughout his career. He lobbied to create Negro History Week in 1926, choosing February to align with the birth month of abolitionist Frederick Douglass and president Abraham Lincoln. Since 1976, the month of February has been designated as a time to honor and pay tribute to the role of African Americans in shaping American history and culture. Donna M. Christensen Donna M. Christensen was thefirst w...
Source: IntraHealth International - Category: International Medicine & Public Health Authors: Source Type: news

Related Links:

A government report found medical facilities stretched to capacity and in need of everything from ventilators to thermometers. Prime Minister Boris Johnson of Britain was in the hospital. Iran moved to end a shutdown of businesses.
Source: NYT Health - Category: Consumer Health News Tags: Coronavirus (2019-nCoV) Hydroxychloroquine (Drug) Tests (Medical) Epidemics United States Politics and Government Unemployment Elizabeth II, Queen of Great Britain Johnson, Boris Trump, Donald J Fauci, Anthony S Source Type: news
This study aims to assess the impact of miR-149 rs2292832 C/T polymorphism and miR-149-5p expressions in cytotoxic effect of temozolomide against glioma cells. A total of 137 cases of glioma patients and 21 healthy cases were enrolled in this study for clinical research. We found that miR-149-5p was significantly downregulated in glioma cell lines and in blood leukocyte of glioma patients. Furthermore, miR-149 rs2292832 C/T polymorphism was significantly associated with glioma prognosis and temozolomide resistance. Subsequently, the glioma cell lines stable transfected with common miR-149 expression construct (miR-149-T) a...
Source: NeuroReport - Category: Neurology Tags: Integrative Systems Source Type: research
Source: BMJ News - Category: General Medicine Source Type: research
The steep rise in coronavirus deaths in New York appears to be leveling off in a possible sign that social distancing is working in the most lethal hot spot in the United States
Source: ABC News: Health - Category: Consumer Health News Tags: Health Source Type: news
Funding to enhance nursing education and strengthen the nursing workforce through experiential learning opportunities, including the use of simulation-based technology to improve the health of patients, families, and communities in rural and medically underserved areas experiencing diseases and conditions that affect public health. Geographic coverage: Nationwide -- Health Resources and Services Administration, U.S. Department of Health and Human Services
Source: AIDS and HIV funding opportunities via the Rural Assistance Center - Category: Infectious Diseases Source Type: funding
Purpose of review The available vaccine and therapies against hepatitis B virus (HBV) rarely eliminate chronic infection with the virus. High mortality resulting from complicating cirrhosis and hepatocellular carcinoma makes improving anti-HBV therapy an important priority. Recent advances with using gene therapy to counter HBV have potential and are the focus of this review. Recent findings The stable replication-competent HBV intermediate comprising covalently closed circular DNA (cccDNA) is the template for expression of all viral genes. Inactivating cccDNA has thus been a focus of research aimed at achieving cure ...
Source: Current Opinion in HIV and AIDS - Category: Infectious Diseases Tags: HIV AND HEPATITIS B CURE: Edited by Sharon R. Lewin and Peter A. Revill Source Type: research
Purpose of review The cure for hepatitis C virus infection has raised hope for a potential hepatitis B virus (HBV) cure, but the high price tag has led to serious questions about the affordability, and thus to access for all. This review discusses cost-effectiveness models, affordability, and access to a potential new cure for chronic HBV infection. Recent findings A cure does not yet exist for HBV, but the antiviral treatments that are currently available help slow down the progression of disease. There is limited research in the area of cost-effectiveness and economic analysis comparing a potential cure. Our prelimi...
Source: Current Opinion in HIV and AIDS - Category: Infectious Diseases Tags: HIV AND HEPATITIS B CURE: Edited by Sharon R. Lewin and Peter A. Revill Source Type: research
No abstract available
Source: Current Opinion in HIV and AIDS - Category: Infectious Diseases Tags: EDITORIAL INTRODUCTIONS Source Type: research
No abstract available
Source: Current Opinion in HIV and AIDS - Category: Infectious Diseases Tags: HIV AND HEPATITIS B CURE: Edited by Sharon R. Lewin and Peter A. Revill Source Type: research
Purpose of review The aim of this study was to identify similarities, differences and lessons to be shared from recent progress in HIV and hepatitis B virus (HBV) immunotherapeutic approaches. Recent findings Immune dysregulation is a hallmark of both HIV and HBV infection, which have shared routes of transmission, with approximately 10% of HIV-positive patients worldwide being coinfected with HBV. Immune modulation therapies to orchestrate effective innate and adaptive immune responses are currently being sought as potential strategies towards a functional cure in both HIV and HBV infection. These are based on activa...
Source: Current Opinion in HIV and AIDS - Category: Infectious Diseases Tags: HIV AND HEPATITIS B CURE: Edited by Sharon R. Lewin and Peter A. Revill Source Type: research
More News: AIDS Vaccine | Blood Transusion | Cancer | Cancer & Oncology | Cancer Vaccines | Cervical Cancer | Child Development | Children | Graduation | Harvard | Health Management | Hematology | History of Medicine | HIV AIDS | International Medicine & Public Health | Microbiology | Nurses | Nursing | Polio | Polio Vaccine | Politics | Sickle Cell Anemia | Smokers | Study | Syphilis | University of Pennsylvania | USA Health | Vaccines | Women